- Home
- CRBP vs PLBC Comparison
CRBP vs PLBC Comparison
Compare CRBP & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PLBC
- Stock Information
- Founded
- CRBP 2009
- PLBC 1980
- Country
- CRBP United States
- PLBC United States
- Employees
- CRBP N/A
- PLBC N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PLBC Finance Companies
- Sector
- CRBP Health Care
- PLBC Finance
- Exchange
- CRBP Nasdaq
- PLBC Nasdaq
- Market Cap
- CRBP 227.3M
- PLBC 253.9M
- IPO Year
- CRBP N/A
- PLBC 2005
- Fundamental
- Price
- CRBP $16.73
- PLBC $46.93
- Analyst Decision
- CRBP Strong Buy
- PLBC Buy
- Analyst Count
- CRBP 7
- PLBC 1
- Target Price
- CRBP $65.86
- PLBC $45.00
- AVG Volume (30 Days)
- CRBP 346.4K
- PLBC 15.1K
- Earning Date
- CRBP 11-07-2024
- PLBC 01-15-2025
- Dividend Yield
- CRBP N/A
- PLBC 2.31%
- EPS Growth
- CRBP N/A
- PLBC N/A
- EPS
- CRBP N/A
- PLBC 4.77
- Revenue
- CRBP N/A
- PLBC $79,873,000.00
- Revenue This Year
- CRBP N/A
- PLBC N/A
- Revenue Next Year
- CRBP N/A
- PLBC $30.32
- P/E Ratio
- CRBP N/A
- PLBC $9.75
- Revenue Growth
- CRBP N/A
- PLBC 3.64
- 52 Week Low
- CRBP $4.00
- PLBC $32.50
- 52 Week High
- CRBP $61.90
- PLBC $47.56
- Technical
- Relative Strength Index (RSI)
- CRBP 37.25
- PLBC 64.74
- Support Level
- CRBP $15.65
- PLBC $45.62
- Resistance Level
- CRBP $17.18
- PLBC $47.56
- Average True Range (ATR)
- CRBP 1.26
- PLBC 1.35
- MACD
- CRBP 0.35
- PLBC 0.19
- Stochastic Oscillator
- CRBP 21.09
- PLBC 91.52
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.